PRICE T ROWE ASSOCIATES INC /MD/ - CITIUS PHARMACEUTICALS INC ownership

CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 78 filers reported holding CITIUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of CITIUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$18
-69.5%
25,009
-48.4%
0.00%
Q2 2023$59
+110.7%
48,509
+106.4%
0.00%
Q1 2023$28
+55.6%
23,500
+4.9%
0.00%
Q4 2022$18
-99.9%
22,4000.0%0.00%
Q3 2022$28,000
+33.3%
22,4000.0%0.00%
Q2 2022$21,000
-43.2%
22,400
+7.1%
0.00%
Q1 2022$37,000
+37.0%
20,909
+18.7%
0.00%
Q4 2021$27,000
-32.5%
17,609
-10.2%
0.00%
Q3 2021$40,000
-39.4%
19,609
+3.2%
0.00%
Q2 2021$66,000
+247.4%
19,009
+82.8%
0.00%
Q1 2021$19,000
+72.7%
10,4000.0%0.00%
Q4 2020$11,00010,4000.00%
Other shareholders
CITIUS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Inspire Advisors, LLC 188,796$291,0000.08%
Horst & Graben Wealth Management LLC 75,722$117,0000.03%
Alpine Global Management, LLC 83,475$129,0000.02%
Miller Investment Management, LP 50,000$77,0000.01%
SABBY MANAGEMENT, LLC 30,863$48,0000.01%
WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC 49,075$76,0000.00%
Alberta Investment Management Corp 172,185$265,0000.00%
Syverson Strege & Co 2,145$3,0000.00%
HighTower Advisors, LLC 170,623$263,0000.00%
HRT FINANCIAL LP 90,871$139,0000.00%
View complete list of CITIUS PHARMACEUTICALS INC shareholders